ESMO 2026 - Oncotype DX: Evidence from Egypt with Dr. Hatem Azim

Genomic testing through an Egyptian lens. Dr. Hatem Azim explores the role of Oncotype DX in breast cancer treatment decisions, bringing attention to a population underrepresented in research and the challenges of test access.